Primary Headache Disorders

Dental Clinics of North America

Volumn 57, Issue 3, 2013, Pages 513-539

  Benoliel, Rafael ^a   Eliav, Eli ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Hemicrania continua; Migraine; Tension type headaches; Trigeminal autonomic cephalgias

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; INDOMETACIN; LAMOTRIGINE; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR; SUMATRIPTAN; TRIAZINE DERIVATIVE; VASOCONSTRICTOR AGENT;

CHRONIC DISEASE; CLUSTER HEADACHE; DIFFERENTIAL DIAGNOSIS; HUMAN; MIGRAINE; PAROXYSMAL HEMICRANIA; PATHOPHYSIOLOGY; PRIMARY HEADACHE; REVIEW; SUNCT SYNDROME; TENSION HEADACHE; TRIGEMINAL AUTONOMIC CEPHALALGIA;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTICONVULSANTS; CHRONIC DISEASE; CLUSTER HEADACHE; CYCLOOXYGENASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; HEADACHE DISORDERS, PRIMARY; HUMANS; INDOMETHACIN; MIGRAINE DISORDERS; PAROXYSMAL HEMICRANIA; SUMATRIPTAN; SUNCT SYNDROME; TENSION-TYPE HEADACHE; TRIAZINES; TRIGEMINAL AUTONOMIC CEPHALALGIAS; VASOCONSTRICTOR AGENTS;

EID: 84883280671     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2013.04.005     Document Type: Review

References (207)

1. The International classification of headache disorders. 2nd edition. 2004. Available at: Accessed October 9, 2011. http://ihs-classification.org/en/.
2. Henry P., Michel P., Brochet B., et al. Anationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia 1992, 12(4):229-237. [discussion: 186].
3. O'Brien B., Goeree R., Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol 1994, 23(5):1020-1026.
4. Stewart W.F., Lipton R.B., Celentano D.D., et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992, 267(1):64-69.
5. Rasmussen B.K., Jensen R., Schroll M., et al. Epidemiology of headache in a general population-a prevalence study. JClin Epidemiol 1991, 44(11):1147-1157.
6. Olesen J. The migraines: introduction. The headaches 2000, 223-225. Lippincott Williams & Wilkins, Philadelphia. 2nd edition. J. Olesen, P. Tfelt-Hansen, K.M. Welch (Eds.).
7. Cavallini A., Micieli G., Bussone G., et al. Headache and quality of life. Headache 1995, 35(1):29-35.
8. Steiner T.J. Headache burdens and bearers. Funct Neurol 2000, 15(Suppl 3):219-223.
9. Steiner T.J., Scher A.I., Stewart W.F., et al. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 2003, 23(7):519-527.
10. Russell M.B., Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ 1995, 311(7004):541-544.
11. Stewart W.F., Staffa J., Lipton R.B., et al. Familial risk of migraine: a population-based study. Ann Neurol 1997, 41(2):166-172.
12. Estevez M., Gardner K.L. Update on the genetics of migraine. Hum Genet 2004, 114(3):225-235.
13. Mochi M., Cevoli S., Cortelli P., et al. Agenetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci 2003, 23(6):301-305.
14. Giffin N.J., Ruggiero L., Lipton R.B., et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003, 60(6):935-940.
15. Kelman L. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 2004, 44(9):865-872.
16. Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia 2004, 24(9):728-734.
17. Kelman L. Migraine pain location: a tertiary care study of 1283 migraineurs. Headache 2005, 45(8):1038-1047.
18. Rasmussen B.K., Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992, 12(4):221-228. [discussion: 186].
19. Rasmussen B.K., Jensen R., Olesen J. Apopulation-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991, 11(3):129-134.
20. Russell M.B., Rasmussen B.K., Fenger K., et al. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996, 16(4):239-245.
21. Stewart W.F., Lipton R.B., Kolodner K. Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms. Headache 2003, 43(3):258-265.
22. Rasmussen B.K., Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology 1992, 42(6):1225-1231.
23. Zagami A.S., Rasmussen B.K. Symptomatology of migraine. The headaches 2000, 337-343. Lippincott Williams and Wilkins, Philadelphia. 2nd edition. J. Olesen, P. Tfelt-Hansen, K.M. Welch (Eds.).
24. Pryse-Phillips W., Findlay H., Tugwell P., et al. ACanadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992, 19(3):333-339.
25. Rasmussen P. Facial pain. IV. A prospective study of 1052 patients with a view of: precipitating factors, associated symptoms, objective psychiatric and neurological symptoms. Acta Neurochir (Wien) 1991, 108(3-4):100-109.
26. Barbanti P., Fabbrini G., Pesare M., et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia 2002, 22(4):256-259.
27. Kaup A.O., Mathew N.T., Levyman C., et al. 'Side locked' migraine and trigeminal autonomic cephalgias: evidence for clinical overlap. Cephalalgia 2003, 23(1):43-49.
28. Martin V.T., Behbehani M.M. Toward a rational understanding of migraine trigger factors. Med Clin North Am 2001, 85(4):911-941.
29. Chabriat H., Danchot J., Michel P., et al. Precipitating factors of headache. A prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Headache 1999, 39(5):335-338.
30. Rasmussen B.K. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993, 53(1):65-72.
31. Spierings E.L., Ranke A.H., Honkoop P.C. Precipitating and aggravating factors of migraine versus tension-type headache. Headache 2001, 41(6):554-558.
32. Kelman L., Rains J.C. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 2005, 45(7):904-910.
33. Dodick D.W., Eross E.J., Parish J.M., et al. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache 2003, 43(3):282-292.
34. Granella F., Sances G., Allais G., et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004, 24(9):707-716.
35. Couturier E.G., Bomhof M.A., Neven A.K., et al. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003, 23(4):302-308.
36. Martin V.T., Wernke S., Mandell K., et al. Defining the relationship between ovarian hormones and migraine headache. Headache 2005, 45(9):1190-1201.
37. Granella F., Sances G., Pucci E., et al. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000, 20(8):701-707.
38. Robbins L. Precipitating factors in migraine: a retrospective review of 494 patients. Headache 1994, 34(4):214-216.
39. Rasmussen B.K. Epidemiology of headache. Cephalalgia 2001, 21(7):774-777.
40. Karli N., Zarifoglu M., Calisir N., et al. Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology?. Cephalalgia 2005, 25(6):444-451.
41. Zebenholzer K., Wober C., Kienbacher C., et al. Migrainous disorder and headache of the tension-type not fulfilling the criteria: a follow-up study in children and adolescents. Cephalalgia 2000, 20(7):611-616.
42. Benoliel R., Elishoov H., Sharav Y. Orofacial pain with vascular-type features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 84(5):506-512.
43. Penarrocha M., Bandres A., Penarrocha M., et al. Lower-half facial migraine: a report of 11 cases. JOral Maxillofac Surg 2004, 62(12):1453-1456.
44. Daudia A.T., Jones N.S. Facial migraine in a rhinological setting. Clin Otolaryngol Allied Sci 2002, 27(6):521-525.
45. Lance J.W., Goadsby P.J. Mechanism and management of headache 2005, Elsevier, Philadelphia. 7th edition.
46. Eross E., Dodick D., Eross M. The Sinus, Allergy and Migraine Study (SAMS). Headache 2007, 47(2):213-224.
47. Schreiber C.P., Hutchinson S., Webster C.J., et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache. Arch Intern Med 2004, 164(16):1769-1772.
48. Campbell J.K., Sakai F. The migraines: diagnosis and differential diagnosis. The headaches 2000, Lippincott Williams & Wilkins, Philadelphia. 2nd edition. J. Olesen, P. Tfelt-Hansen, K.M. Welch (Eds.).
49. Evidence-based guidelines in the primary care setting: neuroimaging in patients with nonacute headache 2000, American Academy of Neurology, Available at:, Accessed May 17, 2013. http://www.aan.com/professionals/practice/pdfs/gl0088.pdf.
50. Sandrini G., Friberg L., Janig W., et al. Neurophysiological tests and neuroimaging procedures in non-acute headache: guidelines and recommendations. Eur J Neurol 2004, 11(4):217-224.
51. Lipton R.B., Pan J. Is migraine a progressive brain disease?. JAMA 2004, 291(4):493-494.
52. Lipton R.B., Bigal M.E. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005, 45(Suppl 1):S3-S13.
53. Katsarava Z., Schneeweiss S., Kurth T., et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004, 62(5):788-790.
54. Scher A.I., Stewart W.F., Ricci J.A., et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003, 106(1-2):81-89.
55. Krymchantowski A.V., Moreira P.F. Clinical presentation of transformed migraine: possible differences among male and female patients. Cephalalgia 2001, 21(5):558-566.
56. Spierings E.L., Schroevers M., Honkoop P.C., et al. Presentation of chronic daily headache: a clinical study. Headache 1998, 38(3):191-196.
57. Mathew N.T., Reuveni U., Perez F. Transformed or evolutive migraine. Headache 1987, 27(2):102-106.
58. Solomon S., Lipton R.B., Newman L.C. Clinical features of chronic daily headache. Headache 1992, 32(7):325-329.
59. Srikiatkhachorn A., Phanthumchinda K. Prevalence and clinical features of chronic daily headache in a headache clinic. Headache 1997, 37(5):277-280.
60. Peres M.F., Sanchez del Rio M., Seabra M.L., et al. Hypothalamic involvement in chronic migraine. JNeurol Neurosurg Psychiatry 2001, 71(6):747-751.
61. Merikangas K.R., Rasmussen B.K. Migraine comorbidity. The headaches 2000, 235-240. Lippincott Williams and Wilkins, Philadelphia. 2nd edition. J. Olesen, P. Tfelt-Hansen, K.M. Welch (Eds.).
62. Scher A.I., Bigal M.E., Lipton R.B. Comorbidity of migraine. Curr Opin Neurol 2005, 18(3):305-310.
63. Pietrobon D., Moskowitz M.A. Pathophysiology of migraine. Annu Rev Physiol 2012, 75:365-391.
64. Edvinsson L., Villalon C.M., Maassenvandenbrink A. Basic mechanisms of migraine and its acute treatment. Pharmacol Ther 2012, 136(3):319-333.
65. Pryse-Phillips W.E., Dodick D.W., Edmeads J.G., et al. Guidelines for the nonpharmacologic management of migraine in clinical practice. Canadian Headache Society. CMAJ 1998, 159(1):47-54.
66. Holland S., Silberstein S.D., Freitag F., et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012, 78(17):1346-1353.
67. Dodick D.W., Lipton R.B., Ferrari M.D., et al. Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project. Curr Pain Headache Rep 2004, 8(6):435-442.
68. Ferrari M.D., Goadsby P.J., Roon K.I., et al. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002, 22(8):633-658.
69. Savi L., Omboni S., Lisotto C., et al. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. JHeadache Pain 2011, 12(6):609-615.
70. Silberstein S.D., Holland S., Freitag F., et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012, 78(17):1337-1345.
71. MacGregor E.A., Pawsey S.P., Campbell J.C., et al. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: results of a new analysis of data from five previously published studies. Gend Med 2010, 7(2):88-108.
72. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine 2000, US Headache Consortium, American Academy of Neurology, Available at:, Accessed October 2005. http://www.aan.com/professionals/practice/pdfs/gl0090.pdf.
73. Silberstein S.D., Goadsby P.J., Lipton R.B. Management of migraine: an algorithmic approach. Neurology 2000, 55(9 Suppl 2):S46-S52.
74. Loder E., Biondi D. General principles of migraine management: the changing role of prevention. Headache 2005, 45(Suppl 1):S33-S47.
75. Welch K.M., Nagesh V., Aurora S.K., et al. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?. Headache 2001, 41(7):629-637.
76. Chronicle E., Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev 2004, (3). CD003226.
77. Silberstein S.D., Goadsby P.J. Migraine: preventive treatment. Cephalalgia 2002, 22(7):491-512.
78. Goadsby P.J. Advances in the understanding of headache. Br Med Bull 2005, 73-74:83-92.
79. Dahlof C.G. Management of primary headaches: current and future aspects. Pain 2002- An updated review: refresher course 2002, 85-112. IASP Press, Seattle (WA). M.A. Giamberardino (Ed.).
80. Leone M., Proietti Cecchini A., Franzini A., et al. From neuroimaging to patients' bench: what we have learnt from trigemino-autonomic pain syndromes. Neurol Sci 2012, 33(Suppl 1):S99-S102.
81. Holle D., Katsarava Z., Obermann M. The hypothalamus: specific or nonspecific role in the pathophysiology of trigeminal autonomic cephalalgias?. Curr Pain Headache Rep 2011, 15(2):101-107.
82. Leone M., Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol 2009, 8(8):755-764.
83. Manzoni G.C., Terzano M.G., Bono G., et al. Cluster headache-clinical findings in 180 patients. Cephalalgia 1983, 3(1):21-30.
84. Fischera M., Marziniak M., Gralow I., et al. The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia 2008, 28(6):614-618.
85. Sjaastad O., Bakketeig L.S. Cluster headache prevalence. Vaga study of headache epidemiology. Cephalalgia 2003, 23(7):528-533.
86. Benoliel R., Sharav Y. Trigeminal autonomic cephalgias (TACs). Orofacial pain and headache 2008, 223-254. Mosby Elsevier, Edinburgh (United Kingdom). Y. Sharav, R. Benoliel (Eds.).
87. van Vliet J.A., Eekers P.J., Haan J., et al. Features involved in the diagnostic delay of cluster headache. JNeurol Neurosurg Psychiatry 2003, 74(8):1123-1125.
88. Manzoni G.C., Micieli G., Granella F., et al. Cluster headache-course over ten years in 189 patients. Cephalalgia 1991, 11(4):169-174.
89. Bahra A., Goadsby P.J. Diagnostic delays and mis-management in cluster headache. Acta Neurol Scand 2004, 109(3):175-179.
90. Klapper J.A., Klapper A., Voss T. The misdiagnosis of cluster headache: a nonclinic, population-based, Internet survey. Headache 2000, 40(9):730-735.
91. Larner A.J. Trigeminal autonomic cephalalgias: frequency in a general neurology clinic setting. JHeadache Pain 2008, 9(5):325-326.
92. Van Alboom E., Louis P., Van Zandijcke M., et al. Diagnostic and therapeutic trajectory of cluster headache patients in Flanders. Acta Neurol Belg 2009, 109(1):10-17.
93. Cademartiri C., Torelli P., Cologno D., et al. Upper and lower cluster headache: clinical and pathogenetic observations in 608 patients. Headache 2002, 42(7):630-637.
94. Bahra A., May A., Goadsby P.J. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002, 58(3):354-361.
95. Torelli P., Manzoni G.C. Pain and behaviour in cluster headache. A prospective study and review of the literature. Funct Neurol 2003, 18(4):205-210.
96. Russell D. Cluster headache: severity and temporal profiles of attacks and patient activity prior to and during attacks. Cephalalgia 1981, 1(4):209-216.
97. Pfaffenrath V., Pollmann W., Ruther E., et al. Onset of nocturnal attacks of chronic cluster headache in relation to sleep stages. Acta Neurol Scand 1986, 73(4):403-407.
98. Chervin R.D., Zallek S.N., Lin X., et al. Timing patterns of cluster headaches and association with symptoms of obstructive sleep apnea. Sleep Res Online 2000, 3(3):107-112.
99. Schurks M., Diener H.C. Cluster headache and lifestyle habits. Curr Pain Headache Rep 2008, 12(2):115-121.
100. Torelli P., Cologno D., Cademartiri C., et al. Possible predictive factors in the evolution of episodic to chronic cluster headache. Headache 2000, 40(10):798-808.
101. Blau J.N., Engel H.O. Premonitory and prodromal symptoms in cluster headache. Cephalalgia 1998, 18(2):91-93. [discussion: 71-2].
102. Langedijk M., van der Naalt J., Luijckx G.J., et al. Cluster-like headache aura status. Headache 2005, 45(1):80-81.
103. Drummond P.D. Dissociation between pain and autonomic disturbances in cluster headache. Headache 1990, 30(8):505-508.
104. Wheeler S.D. Significance of migrainous features in cluster headache: divalproex responsiveness. Headache 1998, 38(7):547-551.
105. Irimia P., Cittadini E., Paemeleire K., et al. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia 2008, 28(6):626-630.
106. Levy M.J., Matharu M.S., Meeran K., et al. The clinical characteristics of headache in patients with pituitary tumours. Brain 2005, 128(Pt 8):1921-1930.
107. Manzoni G.C. Cluster headache and lifestyle: remarks on a population of 374 male patients. Cephalalgia 1999, 19(2):88-94.
108. Cittadini E., Matharu M.S. Symptomatic trigeminal autonomic cephalalgias. Neurologist 2009, 15(6):305-312.
109. Favier I., van Vliet J.A., Roon K.I., et al. Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. Arch Neurol 2007, 64(1):25-31.
110. Trucco M., Mainardi F., Maggioni F., et al. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT syndrome in association with other pathologies: a review. Cephalalgia 2004, 24(3):173-184.
111. Wilbrink L.A., Ferrari M.D., Kruit M.C., et al. Neuroimaging in trigeminal autonomic cephalgias: when, how, and of what?. Curr Opin Neurol 2009, 22(3):247-253.
112. Goadsby P.J., Cittadini E., Cohen A.S. Trigeminal autonomic cephalalgias: paroxysmal hemicrania, SUNCT/SUNA, and hemicrania continua. Semin Neurol 2010, 30(2):186-191.
113. Dodick D.W., Rozen T.D., Goadsby P.J., et al. Cluster headache. Cephalalgia 2000, 20(9):787-803.
114. Ashkenazi A., Schwedt T. Cluster headache-acute and prophylactic therapy. Headache 2011, 51(2):272-286.
115. Rozen T.D. Trigeminal autonomic cephalalgias. Neurol Clin 2009, 27(2):537-556.
116. Rozen T.D. High oxygen flow rates for cluster headache. Neurology 2004, 63(3):593.
117. Antonaci F., Costa A., Candeloro E., et al. Single high-dose steroid treatment in episodic cluster headache. Cephalalgia 2005, 25(4):290-295.
118. Benoliel R. Trigeminal autonomic cephalgias. B J Pain 2012, 6(3):106-123.
119. Paemeleire K., Evers S., Goadsby P.J. Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep 2008, 12(2):122-127.
120. Goadsby P.J., Cittadini E., Burns B., et al. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol 2008, 21(3):323-330.
121. Koopman J.S., Dieleman J.P., Huygen F.J., et al. Incidence of facial pain in the general population. Pain 2009, 147(1-3):122-127.
122. Obermann M., Katsarava Z. Epidemiology of unilateral headaches. Expert Rev Neurother 2008, 8(9):1313-1320.
123. Sjaastad O., Bakketeig L.S. The rare, unilateral headaches. Vaga study of headache epidemiology. JHeadache Pain 2007, 8(1):19-27.
124. Antonaci F., Sjaastad O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989, 29(10):648-656.
125. Boes C.J., Dodick D.W. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache 2002, 42(8):699-708.
126. Kudrow D.B., Kudrow L. Successful aspirin prophylaxis in a child with chronic paroxysmal hemicrania. Headache 1989, 29(5):280-281.
127. Matharu M.S., Goadsby P.J. Bilateral paroxysmal hemicrania or bilateral paroxysmal cephalgia, another novel indomethacin-responsive primary headache syndrome?. Cephalalgia 2005, 25(2):79-81.
128. Boes C.J., Vincent M., Russell D. Chronic paroxysmal hemicrania. The headaches 2006, 815-822. Lippincott Williams & Wilkins, Philadelphia. 3rd edition. J. Olesen, P.J. Goadsby, N.M. Ramadan (Eds.).
129. Sarlani E., Schwartz A.H., Greenspan J.D., et al. Chronic paroxysmal hemicrania: a case report and review of the literature. JOrofac Pain 2003, 17(1):74-78.
130. Siow H.C. Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors. Cephalalgia 2004, 24(5):414-415.
131. Sahota P.K., Dexter J.D. Sleep and headache syndromes: a clinical review. Headache 1990, 30(2):80-84.
132. Benoliel R., Sharav Y. Paroxysmal hemicrania. Case studies and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85(3):285-292.
133. Cittadini E., Matharu M.S., Goadsby P.J. Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain 2008, 131(Pt 4):1142-1155.
134. Mariano da Silva H., Benevides-Luz I., Santos A.C., et al. Chronic paroxysmal hemicrania as a manifestation of intracranial parotid gland carcinoma metastasis-a case report. Cephalalgia 2004, 24(3):223-227.
135. Gatzonis S., Mitsikostas D.D., Ilias A., et al. Two more secondary headaches mimicking chronic paroxysmal hemicrania. Is this the exception or the rule?. Headache 1996, 36(8):511-513.
136. Pareja J., Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua. Interval between indomethacin administration and response. Headache 1996, 36(1):20-23.
137. Sjaastad O., Antonaci F. Chronic paroxysmal hemicrania: a case report. Long-lasting remission in the chronic stage. Cephalalgia 1987, 7(3):203-205.
138. Camarda C., Camarda R., Monastero R. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: two case reports. Clin Neurol Neurosurg 2008, 110(1):88-91.
139. Cohen A.S., Goadsby P.J. Paroxysmal hemicrania responding to topiramate. JNeurol Neurosurg Psychiatry 2007, 78(1):96-97.
140. Sjaastad O., Saunte C., Salvesen R., et al. Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea. Cephalalgia 1989, 9(2):147-156.
141. Sjaastad O., Kruszewski P. Trigeminal neuralgia and "SUNCT" syndrome: similarities and differences in the clinical pictures. An overview. Funct Neurol 1992, 7(2):103-107.
142. Pareja J.A., Cuadrado M.L. SUNCT syndrome: an update. Expert Opin Pharmacother 2005, 6(4):591-599.
143. Matharu M.S., Cohen A.S., Boes C.J., et al. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review. Curr Pain Headache Rep 2003, 7(4):308-318.
144. D'Andrea G., Granella F. SUNCT syndrome: the first case in childhood. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia 2001, 21(6):701-702.
145. Gantenbein A.R., Goadsby P.J. Familial SUNCT. Cephalalgia 2005, 25(6):457-459.
146. Cohen A.S., Matharu M.S., Goadsby P.J. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)-a prospective clinical study of SUNCT and SUNA. Brain 2006, 129(Pt 10):2746-2760.
147. Pareja J.A., Shen J.M., Kruszewski P., et al. SUNCT syndrome: duration, frequency, and temporal distribution of attacks. Headache 1996, 36(3):161-165.
148. Pareja J.A., Caballero V., Sjaastad O. SUNCT syndrome. Statuslike pattern. Headache 1996, 36(10):622-624.
149. Baldacci F., Nuti A., Lucetti C., et al. SUNA syndrome with seasonal pattern. Headache 2009, 49(6):912-914.
150. Benoliel R., Sharav Y. Trigeminal neuralgia with lacrimation or SUNCT syndrome?. Cephalalgia 1998, 18(2):85-90.
151. Kruszewski P., Zhao J.M., Shen J.M., et al. SUNCT syndrome: forehead sweating pattern. Cephalalgia 1993, 13(2):108-113.
152. Jacob S., Rajabally Y. Short-lasting unilateral neuralgiform headache with cranial autonomic symptoms (SUNA) following vertebral artery dissection. Cephalalgia 2007, 27(3):283-285.
153. Jimenez Caballero P.E., Portilla Cuenca J.C., Casado Naranjo I. Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) secondary to epidermoid cyst in the right cerebellopontine angle successfully treated with surgery. JHeadache Pain 2011, 12(3):385-387.
154. Williams M.H., Broadley S.A. SUNCT and SUNA: clinical features and medical treatment. JClin Neurosci 2008, 15(5):526-534.
155. Pareja J.A., Kruszewski P., Sjaastad O. SUNCT syndrome: trials of drugs and anesthetic blockades. Headache 1995, 35(3):138-142.
156. Morales-Asin F., Espada F., Lopez-Obarrio L.A., et al. ASUNCT case with response to surgical treatment. Cephalalgia 2000, 20(1):67-68.
157. Benoliel R., Sharav Y. SUNCT syndrome: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85(2):158-161.
158. Pareja J.A., Sjaastad O. SUNCT syndrome. A clinical review. Headache 1997, 37(4):195-202.
159. Rossi P., Faroni J., Tassorelli C., et al. Diagnostic delay and suboptimal management in a referral population with hemicrania continua. Headache 2009, 49(2):227-234.
160. Newman L.C., Lipton R.B., Solomon S. Hemicrania continua: ten new cases and a review of the literature. Neurology 1994, 44(11):2111-2114.
161. Newman L.C., Lipton R.B., Russell M., et al. Hemicrania continua: attacks may alternate sides [see comments]. Headache 1992, 32(5):237-238.
162. Peres M.F., Silberstein S.D., Nahmias S., et al. Hemicrania continua is not that rare. Neurology 2001, 57(6):948-951.
163. Peres M.F., Siow H.C., Rozen T.D. Hemicrania continua with aura. Cephalalgia 2002, 22(3):246-248.
164. Peres M.F., Silberstein S.D. Hemicrania continua responds to cyclooxygenase-2 inhibitors. Headache 2002, 42(6):530-531.
165. Sjaastad O., Antonaci F. Apiroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache 1995, 35(9):549-550.
166. Rasmussen B.K. Epidemiology of headache. Cephalalgia 1995, 15(1):45-68.
167. Lyngberg A.C., Rasmussen B.K., Jorgensen T., et al. Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol 2005, 161(11):1066-1073.
168. Lyngberg A.C., Rasmussen B.K., Jorgensen T., et al. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 2005, 20(3):243-249.
169. Russell M.B. Tension-type headache in 40-year-olds: a Danish population-based sample of 4000. JHeadache Pain 2005, 6(6):441-447.
170. Jensen R., Symon D. Epidemiology of tension-type headache. The headaches 2006, 621-624. Lippincott Williams & Wilkins, Philadelphia. 3rd edition. J. Olesen, P.J. Goadsby, N.M. Ramadan (Eds.).
171. Rasmussen B.K., Jensen R., Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. JEpidemiol Community Health 1992, 46(4):443-446.
172. Stovner L.J., Zwart J.A., Hagen K., et al. Epidemiology of headache in Europe. Eur J Neurol 2006, 13(4):333-345.
173. Ostergaard S., Russell M.B., Bendtsen L., et al. Comparison of first degree relatives and spouses of people with chronic tension headache. BMJ 1997, 314(7087):1092-1093.
174. Ulrich V., Gervil M., Olesen J. The relative influence of environment and genes in episodic tension-type headache. Neurology 2004, 62(11):2065-2069.
175. Iversen H.K., Langemark M., Andersson P.G., et al. Clinical characteristics of migraine and episodic tension-type headache in relation to old and new diagnostic criteria. Headache 1990, 30(8):514-519.
176. Inan L.E., Tulunay F.C., Guvener A., et al. Characteristics of headache in migraine without aura and episodic tension-type headache in the Turkish population according to the IHS classification. Cephalalgia 1994, 14(2):171-173.
177. Gobel H., Petersen-Braun M., Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 1994, 14(2):97-106.
178. Rasmussen B.K. Migraine and tension-type headache are separate disorders. Cephalalgia 1996, 16(4):217-220. [discussion: 223].
179. Olesen J., Bousser M.G., Diener H.C., et al. The International classification of headache disorders, 2nd edition. Cephalalgia 2004, 24(Suppl 1):24-150.
180. Couch J.R. The long-term prognosis of tension-type headache. Curr Pain Headache Rep 2005, 9(6):436-441.
181. Lipton R.B., Cady R.K., Stewart W.F., et al. Diagnostic lessons from the spectrum study. Neurology 2002, 58(9 Suppl 6):S27-S31.
182. Lipton R.B., Stewart W.F., Cady R., et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 2000, 40(10):783-791.
183. Ulrich V., Russell M.B., Jensen R., et al. Acomparison of tension-type headache in migraineurs and in non-migraineurs: a population-based study. Pain 1996, 67(2-3):501-506.
184. Koseoglu E., Nacar M., Talaslioglu A., et al. Epidemiological and clinical characteristics of migraine and tension type headache in 1146 females in Kayseri, Turkey. Cephalalgia 2003, 23(5):381-388.
185. Bigal M.E., Sheftell F.D., Rapoport A.M., et al. Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002, 22(6):432-438.
186. Bendtsen L., Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004, 62(10):1706-1711.
187. Manzoni G.C., Granella F., Sandrini G., et al. Classification of chronic daily headache by International Headache Society criteria: limits and new proposals. Cephalalgia 1995, 15(1):37-43.
188. Jensen R., Rasmussen B.K. Muscular disorders in tension-type headache. Cephalalgia 1996, 16(2):97-103.
189. Bendtsen L., Jensen R., Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996, 53(4):373-376.
190. Langemark M., Olesen J., Poulsen D.L., et al. Clinical characterization of patients with chronic tension headache. Headache 1988, 28(9):590-596.
191. de Filippis S., Salvatori E., Coloprisco G., et al. Headache and mood disorders. JHeadache Pain 2005, 6(4):250-253.
192. Bendtsen L., Fernandez-de-la-Penas C. The role of muscles in tension-type headache. Curr Pain Headache Rep 2011, 15(6):451-458.
193. Bezov D., Ashina S., Jensen R., et al. Pain perception studies in tension-type headache. Headache 2011, 51(2):262-271.
194. Kaniecki R.G. Tension-type headache. Continuum 2012, 18(4):823-834.
195. Mathew N.T., Ashina M. Acute pharmacotherapy of tension-type headaches. The headaches 2006, 727-733. Lippincott Williams & Wilkins, Philadelphia. 3rd edition. J. Olesen, P.J. Goadsby, N.M. Ramadan (Eds.).
196. Steiner T.J., Lange R., Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003, 23(1):59-66.
197. Brennum J., Kjeldsen M., Olesen J. The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia 1992, 12(6):375-379.
198. Cady R.K., Gutterman D., Saiers J.A., et al. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia 1997, 17(5):588-590.
199. Tomkins G.E., Jackson J.L., O'Malley P.G., et al. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 2001, 111(1):54-63.
200. Fumal A., Schoenen J. Chronic tension-type headache. Chronic daily headache 2005, 57-64. BC Decker Inc, Hamilton (Canada). P.J. Goadsby, S.D. Silberstein, D. Dodick (Eds.).
201. Stillman M.J. Pharmacotherapy of tension-type headaches. Curr Pain Headache Rep 2002, 6(5):408-413.
202. Holroyd K.A. Behavioral and psychologic aspects of the pathophysiology and management of tension-type headache. Curr Pain Headache Rep 2002, 6(5):401-407.
203. Bogaards M.C., ter Kuile M.M. Treatment of recurrent tension headache: a meta-analytic review. Clin J Pain 1994, 10(3):174-190.
204. Holroyd K.A., O'Donnell F.J., Stensland M., et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285(17):2208-2215.
205. Fernandez-de-Las-Penas C., Alonso-Blanco C., Cuadrado M.L., et al. Are manual therapies effective in reducing pain from tension-type headache?: a systematic review. Clin J Pain 2006, 22(3):278-285.
206. Magnusson T., Carlsson G.E. A2 1/2-year follow-up of changes in headache and mandibular dysfunction after stomatognathic treatment. JProsthet Dent 1983, 49(3):398-402.
207. Vallon D., Ekberg E., Nilner M., et al. Occlusal adjustment in patients with craniomandibular disorders including headaches. A 3- and 6-month follow-up. Acta Odontol Scand 1995, 53(1):55-59.